Warfarin and INR Monitoring: How Often and What to Expect

What Is Warfarin?

Warfarin is an anticoagulant medication (“blood thinner”) that has been used since the 1950s to prevent and treat blood clots. It works by inhibiting vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver. In the UK, approximately 1.5 million people take warfarin, making it one of the most widely prescribed anticoagulants.

Common indications include atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE), mechanical heart valve replacement, and certain hypercoagulable conditions. Because warfarin has a narrow therapeutic window — too little offers inadequate protection against clots, while too much increases the risk of serious bleeding — regular blood monitoring is essential.

Understanding INR

The International Normalised Ratio (INR) is a standardised measure of how long your blood takes to clot compared to a normal control. It is derived from the prothrombin time (PT). A person not taking anticoagulants typically has an INR of approximately 1.0.

When taking warfarin, the aim is to keep the INR within a specific target range:

• 2.0–3.0: standard range for atrial fibrillation, DVT, PE, and most other indications.
• 2.5–3.5: higher range for patients with mechanical heart valves (particularly mitral valve prostheses) or recurrent thromboembolism despite anticoagulation.

An INR below the target range means your blood is not sufficiently anticoagulated and you are at increased risk of a clot. An INR above the target range means your blood is too thin and you are at increased risk of bleeding.

PT and APTT

The prothrombin time (PT) measures how quickly the extrinsic and common clotting pathways function. INR is calculated from the PT using a standardisation formula, so PT and INR are closely related but INR allows comparison across different laboratories.

The activated partial thromboplastin time (APTT) measures the intrinsic pathway and is not used to monitor warfarin. APTT is instead used for monitoring unfractionated heparin. However, it may be included in a coagulation screen alongside PT/INR.

How Often Should INR Be Tested?

Testing frequency depends on how stable your INR is:

• Starting warfarin: daily or every other day for the first week, then two to three times per week for the next 1–2 weeks.
• Dose adjustments: after any dose change, INR should be rechecked within 1–2 weeks.
• Stable patients: once your INR has been consistently within range, testing intervals can be extended to every 4–8 weeks. NICE suggests a maximum interval of 12 weeks for very stable patients.
• After illness, medication changes, or dietary changes: extra checks may be needed as these can all affect your INR.

Factors That Affect Your INR

Warfarin is notoriously sensitive to interactions. Understanding what affects your INR helps you maintain stable anticoagulation:

• Vitamin K in food: green leafy vegetables (kale, spinach, broccoli, Brussels sprouts) are high in vitamin K, which counteracts warfarin. The advice is not to avoid these foods, but to eat them consistently so your warfarin dose remains calibrated.
• Alcohol: binge drinking raises INR and increases bleeding risk. Regular moderate intake has less effect but can still cause fluctuations.
• Medications: many drugs interact with warfarin. Common examples include antibiotics (especially metronidazole, fluconazole, and macrolides), NSAIDs (increase bleeding risk), and amiodarone (potentiates warfarin). Always inform your anticoagulation clinic when starting or stopping any medication.
• Illness: fever, diarrhoea, and vomiting can all affect INR. Reduced food intake during illness typically increases INR.
• Herbal supplements: St John’s wort, cranberry juice (in large amounts), and ginkgo biloba can interact with warfarin.

Home INR Monitoring

Some patients use point-of-care INR devices (such as the CoaguChek) to test their INR at home using a finger-prick blood sample. Self-monitoring (where the patient tests but the clinic adjusts the dose) and self-management (where the patient both tests and adjusts the dose) have been shown to improve time in therapeutic range and reduce thromboembolic events in motivated, well-trained patients.

Not all patients are suitable for self-monitoring. Your anticoagulation clinic will advise whether this is an option for you. Alternatively, a mobile phlebotomist can take a venous blood sample at your home for laboratory-based INR testing if you find it difficult to attend hospital or GP appointments.

DOACs: The Alternative to Warfarin

Direct oral anticoagulants (DOACs) — including apixaban, rivaroxaban, edoxaban, and dabigatran — have largely replaced warfarin for many indications, particularly atrial fibrillation. Their main advantages over warfarin include:

• No routine INR monitoring required.
• Fewer food and drug interactions.
• Fixed dosing (no dose adjustments based on blood tests).
• Rapid onset and offset of action.

However, warfarin remains the preferred or only option for patients with mechanical heart valves, moderate-to-severe mitral stenosis, and antiphospholipid syndrome. Patients with severe kidney impairment may also be better suited to warfarin. If you are on a DOAC, periodic blood tests (renal function and FBC) are still recommended, typically annually or more frequently if you have kidney disease.

Getting Tested at Home

Regular INR monitoring is essential for safe warfarin therapy, but frequent hospital or GP visits can be burdensome. A mobile phlebotomist can visit your home to take a blood sample for INR testing, making it easier to stay on top of your monitoring schedule. This is particularly valuable for elderly patients, those with mobility issues, or anyone who finds regular clinic attendance difficult. Explore our home blood test services for more details.